BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24528540)

  • 1. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
    Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
    J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.
    Cui X; Chen X; Wang W; Chang A; Yang L; Liu C; Peng H; Wei Y; Liang W; Li S; Wang N; Liu W; Hu J; Zhang W; Wang L; Chen Y; Li F
    Epigenetics; 2017 Aug; 12(8):698-707. PubMed ID: 28703658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.
    Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F
    Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
    Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
    Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
    Lin X; Xu XY; Chen QS; Huang C
    Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC.
    Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F
    Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
    Nie J; Ge X; Geng Y; Cao H; Zhu W; Jiao Y; Wu J; Zhou J; Cao J
    Oncol Rep; 2015 Jul; 34(1):311-7. PubMed ID: 25954903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population.
    Wu F; Li M; You W; Ji Y; Cui X; Hu J; Chen Y; Pang L; Li S; Wei Y; Yang L; Li F
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):29-34. PubMed ID: 29227754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene.
    Chen W; Yang C; Yang L; Qi C; Tian S; Han Y; Dou Y; Ma Y; Tian D; Zheng Y
    Asia Pac J Clin Nutr; 2014; 23(3):488-97. PubMed ID: 25164462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
    Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
    Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.
    Lodygin D; Tarasov V; Epanchintsev A; Berking C; Knyazeva T; Körner H; Knyazev P; Diebold J; Hermeking H
    Cell Cycle; 2008 Aug; 7(16):2591-600. PubMed ID: 18719384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.